Cytokines are also used as therapeutics in clinical settings to specifically stimulate immune responses, including interleukins (ILs) in cancer and colony-stimulating factors (CSFs) in general neutropenia (Mehta et al., 2015; Berraondo et al., 2019; Conlon et al., 2019). This evidence concerns the gene CSF2 and neutropenia.